CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 168 filers reported holding CLOVIS ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $27,000 | -38.6% | 10,000 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $44,000 | -24.1% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $58,000 | -17.1% | 10,000 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $70,000 | +45.8% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $48,000 | -17.2% | 10,000 | 0.0% | 0.00% | -40.0% |
| Q3 2020 | $58,000 | -14.7% | 10,000 | 0.0% | 0.01% | -28.6% |
| Q2 2020 | $68,000 | -99.9% | 10,000 | 0.0% | 0.01% | -22.2% |
| Q1 2020 | $63,600,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |